Skip to main content
. 2014 Jul 29;87(2):87–93. doi: 10.4174/astr.2014.87.2.87

Table 4.

Survival analysis in patients with Bismuth type IV hilar cholangiocarcinomas who underwent curative-intended resection

graphic file with name astr-87-87-i004.jpg

PVE, portal vein embolization; *NC, not calculated (Three in-hospital mortality [two hepatic failure and one pulmonary embolism]) were excluded; papillary or well-differentiated/moderate- or poorly differentiated.